Highbridge Capital Management »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Highbridge Capital Management

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Highbridge Capital Management from 13F filings

Historical chart of Highbridge Capital Management investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Highbridge Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Highbridge Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $51B 50M 1015.44
2023-09-30 $35M 31M 1.12

More positions owned by Highbridge Capital Management

Ishares Tr Option Put Option
Occidental Pete Corp Warrant (Principal) (OXY.WS)
Ford Mtr Co Del Bond (Principal)
Occidental Pete Corp Option Put Option
Liberty Broadband Corp Common (LBRDK)
Nice Bond (Principal)
Gamida Cell Bond (Principal)
Sarepta Therapeutics Bond (Principal)
Integra Lifesciences Hldgs C Bond (Principal)
Pdd Holdings Bond (Principal)
American Airlines Group Bond (Principal)
Lci Inds Bond (Principal)
Tilray Brands Bond (Principal)
Omnicell Bond (Principal)
Sea Bond (Principal)

View all positions for Highbridge Capital Management

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Wolverine Asset Management
Calamos Advisors
Braidwell
Highbridge Capital Management
Davidson Kempner Capital Management
Readystate Asset Management
Bank of America Corporation
Lazard Asset Management
Tenor Capital Management
D. E. Shaw & Co
Bank Of Montreal
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Steelhead Partners
Context Capital Management
Capstone Investment Advisors

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1